Detalles de la búsqueda
1.
The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial.
Cancer Radiother
; 12(6-7): 565-70, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18760649
2.
Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial.
Lancet
; 366(9490): 985-90, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-16168780
3.
Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.
J Clin Oncol
; 15(5): 2040-9, 1997 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-9164216
4.
Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933.
J Clin Oncol
; 17(10): 3143-9, 1999 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-10506611
5.
Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group.
Eur J Cancer
; 40(2): 219-24, 2004 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-14728936
6.
Patient population analysis in EORTC trial 22881/10882 on the role of a booster dose in breast-conserving therapy.
Eur J Cancer
; 30A(14): 2073-81, 1994.
Artículo
en Inglés
| MEDLINE | ID: mdl-7857706
7.
Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group.
Eur J Cancer
; 34(12): 1902-9, 1998 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-10023313
8.
The Quality Assurance programme of the Radiotherapy Group of the European Organization for Research and Treatment of Cancer (EORTC): a critical appraisal of 20 years of continuous efforts.
Eur J Cancer
; 39(4): 430-7, 2003 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-12751372
9.
Can patient-, treatment- and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients?
Eur J Cancer
; 39(7): 932-44, 2003 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-12706362
10.
The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer.
Int J Radiat Oncol Biol Phys
; 45(3): 677-85, 1999 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-10524422
11.
Validation of the methods of cosmetic assessment after breast-conserving therapy in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of Cancer.
Int J Radiat Oncol Biol Phys
; 45(3): 667-76, 1999 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-10524421
12.
A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844.
Int J Radiat Oncol Biol Phys
; 36(3): 549-56, 1996 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-8948338
13.
ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative group of radiotherapy of the european organization for research and treatment of cancer (EORTC).
Radiother Oncol
; 55(2): 111-9, 2000 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-10799722
14.
Postoperative pelvic radiotherapy with or without elective irradiation of para-aortic nodes and liver in rectal cancer patients. A controlled clinical trial of the EORTC Radiotherapy Group.
Radiother Oncol
; 61(1): 7-13, 2001 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-11578723
15.
The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups.
Radiother Oncol
; 55(3): 219-32, 2000 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-10869738
16.
ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by the EORTC.
Radiother Oncol
; 52(2): 149-56, 1999 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-10577700
17.
Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial.
Radiother Oncol
; 44(2): 111-21, 1997 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-9288839
18.
Present status of EORTC trials of hyperfractionated and accelerated radiotherapy on head and neck carcinoma.
Recent Results Cancer Res
; 134: 111-9, 1994.
Artículo
en Inglés
| MEDLINE | ID: mdl-8153427
19.
Effect of aggregated immunoglobulins on mononuclear cell protein production in rheumatoid arthritis.
Clin Immunol Immunopathol
; 49(2): 318-25, 1988 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-3262473
20.
Effect of aggregated IgG on mononuclear and polymorphonuclear cell cooperation.
Rheumatol Int
; 8(1): 35-9, 1988.
Artículo
en Inglés
| MEDLINE | ID: mdl-3363282